LIMONENE
本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。
全球证据概览
所解析的身份在 13 个已索引市场数据集中的 6 个有匹配的监管证据:13 条国家记录和 1 条欧盟附件记录。下方列出每项结果和证据缺口。
已解析的物质身份
(+/-)-1-Methyl-4-(1-methylvinyl)cyclohexene; trans-1-Methyl-4-(1-methylvinyl)cyclohexene
清单限制备注: III/88 III/167 III/168
14 个匹配或报告的名称
全部 13 个市场的监管证据
打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。
滑动或横向滚动以查看数据集覆盖范围和后续操作。
| 市场 | 结果 | 记录 | 数据集 | 含义 / 后续操作 |
|---|---|---|---|---|
| European Union EU | 限用 | 1打开记录 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | 请查看每条关联记录及其确切条件。 |
| Great Britain GB | Restricted | 3打开记录 1打开记录 2 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | 请查看每条关联记录及其确切条件。 |
| Canada CA | 未找到匹配项 | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Restricted | 3打开记录 1打开记录 2 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | 请查看每条关联记录及其确切条件。 |
| ASEAN ASEAN | 未找到匹配项 | 0 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Regional annex coverage does not replace member-state implementation dates, notifications or national deviations. |
| China CN | 未找到匹配项 | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | 未找到匹配项 | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | Prohibited | 3打开记录 1打开记录 2 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | 请查看每条关联记录及其确切条件。 |
| United States US | 未找到匹配项 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | 未找到匹配项 | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | 未找到匹配项 | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | Restricted | 3打开记录 1打开记录 2 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | 请查看每条关联记录及其确切条件。 |
| Saudi Arabia SA | Restricted | 1打开记录 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | 请查看每条关联记录及其确切条件。 |
匹配的市场记录和条件
Great Britain
GB retained Regulation 1223/2009 schedules, effective 15 August 2026New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026South Korea
MFDS Notice 2026-19, effective 18 March 2026India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026附件 II–VI 的精确证据
Limonene
限制: The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products. The peroxide value for each substance shall be less than 20 mmoles/L (This limit applies to the substance and not to the finished cosmetic product).
化学身份与性质

1-Methyl-4-Prop-1-En-2-Ylcyclohexene
Limonene is a monoterpene that is cyclohex-1-ene substituted by a methyl group at position 1 and a prop-1-en-2-yl group at position 4 respectively. It has a role as a human metabolite. It is a cycloalkene and a p-menthadiene. — ChEBI
- IUPAC 名称
- 1-methyl-4-prop-1-en-2-ylcyclohexene
- 分子式
- C10H16
- 分子量
- 136.23 g/mol
- 精确质量
- 136.125200510 Da
- XLogP3
- 3.4
- 拓扑极性表面积
- 0.0 Ų
- 氢键供体
- 0
- 氢键受体
- 0
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:15384
- ChEMBL:CHEMBL15799
- EPA DTXSID:DTXSID2029612
- PubMed:23449869
- PubMed:23074915
- PubMed:23074886
- PubMed:23049473
- PubMed:23030436
- PubMed:23023650
- PubMed:23019456
- PubMed:23019455
- PubMed:23018851
- PubMed:23000832
- PubMed:22978237
- PubMed:22978234
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

(+)-Limonene
(4R)-limonene is an optically active form of limonene having (4R)-configuration. It has a role as a plant metabolite. It is an enantiomer of a (4S)-limonene. — ChEBI
- IUPAC 名称
- (4R)-1-methyl-4-prop-1-en-2-ylcyclohexene
- 分子式
- C10H16
- 分子量
- 136.23 g/mol
- 精确质量
- 136.125200510 Da
- XLogP3
- 3.4
- 拓扑极性表面积
- 0.0 Ų
- 氢键供体
- 0
- 氢键受体
- 0
- 共价单元
- 1
- 已定义的立体中心
- 1
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:15382
- ChEMBL:CHEMBL449062
- EPA DTXSID:DTXSID1020778
- PubMed:22945026
- PubMed:22935404
- PubMed:22888008
- PubMed:22813083
- PubMed:22767881
- PubMed:22732268
- PubMed:22711228
- PubMed:22683953
- PubMed:22683894
- PubMed:22673830
- PubMed:22615620
- PubMed:22615587
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

Limonene, (-)-
(4S)-limonene is an optically active form of limonene having (4S)-configuration. It is an enantiomer of a (4R)-limonene. — ChEBI
- IUPAC 名称
- (4S)-1-methyl-4-prop-1-en-2-ylcyclohexene
- 分子式
- C10H16
- 分子量
- 136.23 g/mol
- 精确质量
- 136.125200510 Da
- XLogP3
- 3.4
- 拓扑极性表面积
- 0.0 Ų
- 氢键供体
- 0
- 氢键受体
- 0
- 共价单元
- 1
- 已定义的立体中心
- 1
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:15383
- ChEMBL:CHEMBL236688
- EPA DTXSID:DTXSID6047078
- PubMed:22905649
- PubMed:22574432
- PubMed:22422313
- PubMed:22072908
- PubMed:21997886
- PubMed:21559976
- PubMed:21485381
- PubMed:21376365
- PubMed:20839638
- PubMed:20569128
- PubMed:20568624
- PubMed:20557909
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

trans-Isolimonene
- IUPAC 名称
- (3S,6S)-3-methyl-6-prop-1-en-2-ylcyclohexene
- 分子式
- C10H16
- 分子量
- 136.23 g/mol
- 精确质量
- 136.125200510 Da
- XLogP3
- 4.0
- 拓扑极性表面积
- 0.0 Ų
- 氢键供体
- 0
- 氢键受体
- 0
- 共价单元
- 1
- 已定义的立体中心
- 2
又称
另有 3 个已报告名称
外部数据库标识符
- EPA DTXSID:DTXSID20897439
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与范围
导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。
打开官方决定